Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Other Non-Current Assets (2016 - 2025)

Immucell's Other Non-Current Assets history spans 16 years, with the latest figure at $37686.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 12.94% year-over-year to $37686.0; the TTM value through Dec 2025 reached $37686.0, up 12.94%, while the annual FY2025 figure was $37686.0, 12.94% up from the prior year.
  • Other Non-Current Assets reached $37686.0 in Q4 2025 per ICCC's latest filing, down from $44345.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $14.0 million in Q4 2022 to a low of $22999.0 in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $739639.5, with a median of $37682.5 recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 53488.96% in 2022, then crashed 99.59% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $26115.0 in 2021, then surged by 53488.96% to $14.0 million in 2022, then plummeted by 99.59% to $57655.0 in 2023, then plummeted by 42.12% to $33368.0 in 2024, then increased by 12.94% to $37686.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Other Non-Current Assets are $37686.0 (Q4 2025), $44345.0 (Q3 2025), and $53619.0 (Q2 2025).